CASI Pharmaceuticals Inc.: Received MNPA (f.k.a. CFDA) approval for EVOMELA® (melphalan for injection: multiple myeloma) on Dec 3, 2018; CFDA review in progress for ZEVALIN® and MARQIBO® (in-licensed from Spectrum Pharma). Acqd 25 US FDA-approved ANDAS from Sandoz in Jan 2018.
Website:
Address:
9620 Medical Center Drive
Suite 300
Rockville, MD 20850
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.